Skip to main content
Premium Trial:

Request an Annual Quote

IU’s NCGAS Launches New Infrastructure Initiatives to Support Biological Research

Premium

The National Center for Genome Analysis Support at Indiana University has launched three new infrastructure initiatives that provide new tools, services, and partners to help biological research communities with their projects.

First, it is now partnering with Pittsburgh Supercomputing Center to provide additional genome analysis applications that will run Blacklight — PSC’s supercomputer — and which will benefit from the system's large memory architecture.

Next, IU has partnered with Penguin Computing to provide researchers with access to a high-performance cluster with large-memory nodes that is configured for genome assembly and equipped with genome analysis and bioinformatics software. The Penguin On-Demand service is available to researchers on a fee-for-service basis.

Finally, NCGAS has updated some of the bioinformatics tools it offers. For example, it now offers an improved version of the Trinity RNA assembly software, which is used by scientists studying gene expression in agricultural pests and human parasites among other organisms.

IU launched NCGAS in 2011 with a three-year $1.4 million grant from the National Science Foundation to provide software, computational resources, and consulting services to NSF-funded researchers (BI 10/7/2011).

Filed under

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.